GE HealthCare Correlations
GEHC Stock | 81.20 1.26 1.53% |
The current 90-days correlation between GE HealthCare Techno and Veeva Systems Class is 0.32 (i.e., Weak diversification). The correlation of GE HealthCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
GE HealthCare Correlation With Market
Weak diversification
The correlation between GE HealthCare Technologies and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GE HealthCare Technologies and DJI in the same portfolio, assuming nothing else is changed.
GEHC |
Moving together with GEHC Stock
0.8 | RVP | Retractable Technologies Earnings Call Tomorrow | PairCorr |
0.7 | HIMS | Hims Hers Health Aggressive Push | PairCorr |
0.66 | MLSS | Milestone Scientific Earnings Call Tomorrow | PairCorr |
0.75 | PLX | Protalix Biotherapeutics | PairCorr |
Moving against GEHC Stock
0.56 | VINC | Vincerx Pharma Earnings Call Tomorrow | PairCorr |
0.39 | ELVN | Enliven Therapeutics Downward Rally | PairCorr |
0.74 | INBX | Inhibrx Symbol Change | PairCorr |
0.68 | ADVM | Adverum Biotechnologies | PairCorr |
0.53 | ZURA | Zura Bio Limited | PairCorr |
0.51 | AVTE | Aerovate Therapeutics | PairCorr |
0.48 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.45 | ATNF | 180 Life Sciences | PairCorr |
0.32 | IMMX | Immix Biopharma | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GEHC Stock performing well and GE HealthCare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GE HealthCare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TDOC | 3.35 | (0.15) | 0.00 | (0.12) | 0.00 | 7.03 | 22.38 | |||
VEEV | 1.35 | 0.10 | 0.06 | 0.14 | 1.56 | 2.87 | 10.69 | |||
TXG | 3.09 | (0.54) | 0.00 | (0.35) | 0.00 | 4.94 | 25.30 | |||
PGNY | 1.94 | 0.60 | 0.30 | 0.76 | 1.54 | 4.11 | 19.60 | |||
SDGR | 3.15 | 0.07 | 0.02 | 0.04 | 3.54 | 6.02 | 21.84 | |||
DOCS | 2.74 | 0.46 | 0.12 | 0.39 | 2.98 | 4.93 | 45.86 | |||
AMWL | 3.50 | 0.01 | 0.00 | 0.01 | 4.24 | 7.67 | 30.99 | |||
GDRX | 2.29 | 0.06 | 0.02 | 0.06 | 2.76 | 5.16 | 13.56 |
GE HealthCare Corporate Executives
Elected by the shareholders, the GE HealthCare's board of directors comprises two types of representatives: GE HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GEHC. The board's role is to monitor GE HealthCare's management team and ensure that shareholders' interests are well served. GE HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GE HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Saccaro | VP CFO | Profile |